Literature DB >> 10496175

Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.

P Diaz-Villoslada1, A Shih, L Shao, C P Genain, S L Hauser.   

Abstract

Autoreactive T cells specific for myelin antigens are thought to play a role in the pathogenesis of multiple sclerosis (MS). We compared T cell proliferative responses in peripheral blood following challenge in vitro with myelin/oligodendrocyte glycoprotein (recombinant protein, rMOG), myelin basic protein (MBP) and proteolipid apoprotein (PLP) in 50 patients with MS and 40 healthy controls. T cell reactivity against rMOG (defined by a specific stimulation index of 2.5 or greater) was present in 13 (26%) MS patients and 12 (30%) healthy controls and was MHC-restricted, as anti-MHC class II antibodies abolished all proliferative responses. By contrast, reactivity against PLP was present in only one (2%) MS patient and six (15%) controls, and no reactivity against MBP was found in any subject. Thus, by the criteria of the present study, an increased reactivity of circulating T cells to MOG is present to a similar degree in healthy individuals and in patients with MS. This finding raises the possibility that additional factors contribute to the pathogenicity of these autoreactive T cell populations in demyelinating disorders of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496175     DOI: 10.1016/s0165-5728(99)00099-5

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

1.  Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.

Authors:  Michael K Axthelm; Dennis N Bourdette; Gail H Marracci; Weiping Su; Elizabeth T Mullaney; Minsha Manoharan; Steven G Kohama; Jim Pollaro; Ellen Witkowski; Paul Wang; William D Rooney; Lawrence S Sherman; Scott W Wong
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

2.  Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.

Authors:  Amanda K Huber; Lu Wang; Peisong Han; Xu Zhang; Sven Ekholm; Ashok Srinivasan; David N Irani; Benjamin M Segal
Journal:  Neurology       Date:  2014-09-24       Impact factor: 9.910

Review 3.  Stage-specific immune dysregulation in multiple sclerosis.

Authors:  Benjamin M Segal
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

Review 4.  Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.

Authors:  H C von Büdingen; N Tanuma; P Villoslada; J C Ouallet; S L Hauser; C P Genain
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

Review 5.  Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.

Authors:  Lisa K Peterson; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2006-12-28       Impact factor: 3.478

6.  Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.

Authors:  Cecilia B Marta; Alfred R Oliver; Rebecca A Sweet; Steven E Pfeiffer; Nancy H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

Review 7.  Vaccines for multiple sclerosis: progress to date.

Authors:  Jorge Correale; Mauricio Farez; Wendy Gilmore
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study.

Authors:  A Van der Aa; N Hellings; R Medaer; G Gelin; Y Palmers; J Raus; P Stinissen
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

9.  Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis.

Authors:  R A Williamson; M P Burgoon; G P Owens; O Ghausi; E Leclerc; L Firme; S Carlson; J Corboy; P W Parren; P P Sanna; D H Gilden; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

10.  Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis.

Authors:  Nieves Vélez de Mendizábal; Jorge Carneiro; Ricard V Solé; Joaquín Goñi; Jean Bragard; Ivan Martinez-Forero; Sara Martinez-Pasamar; Jorge Sepulcre; Javier Torrealdea; Francesca Bagnato; Jordi Garcia-Ojalvo; Pablo Villoslada
Journal:  BMC Syst Biol       Date:  2011-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.